On the heels of its its initial public offering, Connect Biopharma named its first general counsel and appointed an active general counsel to serve on its board of directors.

Jiang Bian, general counsel and chief compliance officer of Connect Biopharma. Courtesy photo

On Monday, the San Diego and Taicang, China-based clinical-stage pharmaceutical company announced the hiring of San Diego lawyer Jiang Bian to serve as general counsel and chief compliance officer, effective Aug. 20. He will report directly to the company’s CEO, Dr. Zheng Wei.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]